- Home
- LDI vs CRDF Comparison
LDI vs CRDF Comparison
Compare LDI & CRDF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDI
- CRDF
- Stock Information
- Founded
- LDI 2010
- CRDF 1999
- Country
- LDI United States
- CRDF United States
- Employees
- LDI N/A
- CRDF N/A
- Industry
- LDI Finance: Consumer Services
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LDI Finance
- CRDF Health Care
- Exchange
- LDI Nasdaq
- CRDF Nasdaq
- Market Cap
- LDI 221.2M
- CRDF 233.5M
- IPO Year
- LDI 2021
- CRDF N/A
- Fundamental
- Price
- LDI $1.96
- CRDF $2.44
- Analyst Decision
- LDI Sell
- CRDF Strong Buy
- Analyst Count
- LDI 2
- CRDF 6
- Target Price
- LDI $2.05
- CRDF $10.58
- AVG Volume (30 Days)
- LDI 2.0M
- CRDF 3.2M
- Earning Date
- LDI 08-07-2025
- CRDF 07-29-2025
- Dividend Yield
- LDI N/A
- CRDF N/A
- EPS Growth
- LDI N/A
- CRDF N/A
- EPS
- LDI N/A
- CRDF N/A
- Revenue
- LDI $1,124,074,000.00
- CRDF $545,000.00
- Revenue This Year
- LDI $26.92
- CRDF N/A
- Revenue Next Year
- LDI $15.27
- CRDF N/A
- P/E Ratio
- LDI N/A
- CRDF N/A
- Revenue Growth
- LDI 27.06
- CRDF N/A
- 52 Week Low
- LDI $1.01
- CRDF $2.09
- 52 Week High
- LDI $3.23
- CRDF $5.64
- Technical
- Relative Strength Index (RSI)
- LDI 61.12
- CRDF 34.95
- Support Level
- LDI $1.77
- CRDF $2.39
- Resistance Level
- LDI $2.02
- CRDF $2.50
- Average True Range (ATR)
- LDI 0.18
- CRDF 0.21
- MACD
- LDI 0.01
- CRDF -0.03
- Stochastic Oscillator
- LDI 79.84
- CRDF 9.93
About LDI loanDepot Inc.
loanDepot Inc provides nonbank consumer lending solutions for individuals in the United States. It offers personal, residential home, home refinancing, mortgage and home equity loans. It also provides online mortgage loans for refinancing and home purchases. It serves customers through distribution channels, including consumer direct centres, retail branches, wholesale centres, and consumer finance and servicing centres in the United States. It competes with commercial banks and financial institutions.
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc is a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical programs in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC"). Geographically, the company only operates in the United States.